APRE - Aprea Therapeutics, Inc.
1.73
-0.020 -1.156%
Share volume: 20,773
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.75
-0.02
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-10-2023 | 11-09-2023 | 11-07-2024 | 05-14-2024 | 08-12-2024 | 11-07-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 249.688 K | 319.468 K | 14.075 K | 380.569 K | 561.574 K | 354.621 K | 205.817 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 249.688 K | 319.468 K | 14.075 K | 380.569 K | 561.574 K | 354.621 K | 205.817 K | |
| inf% | 27.95% | -95.59% | 2,603.87% | 47.56% | -36.85% | -41.96% | |||
| Operating expenses | 4.623 M | 3.901 M | 3.842 M | 3.689 M | 3.530 M | 4.408 M | 4.452 M | 3.432 M | |
| Selling general and admin | 3.366 M | 1.699 M | 1.720 M | 1.643 M | 1.930 M | 1.851 M | 1.605 M | 1.073 M | |
| Research and development | 1.257 M | 2.203 M | 2.123 M | 2.046 M | 1.600 M | 2.558 M | 2.846 M | 2.359 M | |
| Total expenses | 4.623 M | 3.901 M | 3.842 M | 3.689 M | 3.530 M | 4.408 M | 4.452 M | 3.432 M | |
| -15.60% | -1.51% | -3.99% | -4.30% | 24.88% | 0.98% | -22.91% | |||
| Operating income | -4.623 M | -3.652 M | -3.523 M | -3.675 M | -3.150 M | -3.847 M | -4.097 M | -3.226 M | |
| Ebit | -4.636 M | -3.595 M | -3.526 M | -3.754 M | -3.093 M | -3.852 M | -4.133 M | -3.169 M | |
| Pretax income | -4.380 M | -3.259 M | -3.205 M | -3.443 M | -2.810 M | -3.470 M | -3.784 M | -2.895 M | |
| -25.59% | -1.67% | 7.45% | -18.39% | 23.49% | 9.04% | -23.49% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -4.380 M | -3.259 M | -3.205 M | -3.443 M | -2.810 M | -3.470 M | -3.784 M | -2.895 M | |
| 25.59% | 1.67% | -7.45% | 18.39% | -23.49% | -9.04% | 23.49% |
